Moreover, RA effectively inhibited NF-κB ligand (RANKL) which mediated the upregulation of downstream signaling pathways such as NF-κB, MAPK, and SRC/AKT, to affect osteoclast differentiation, which results in bone resorption in breast cancer [69,70,71,72]. The gene discussed is AKT1; the disease is breast carcinoma.